HR3493Referred to Committee
Global Fairness in Drug Pricing Act
Introduced
2
In Committee3
Passed One Chamber4
Passed Both5
Signed into Law119th
Congress
2025-05-19
Introduced
7
Cosponsors
HR
ⓘType
Latest Action
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-05-19
Bill Summary
This bill, known as the Global Fairness in Drug Pricing Act, addresses Global Fairness in Drug Pricing Act. It has been referred to committee for review and possible markup.
Affected Industries
Industries and interest groups with a stake in how this bill is resolved. Compare with each member's outside-money backers on their finance page.
Pharmaceutical
Why this matters: Look up any member who voted on this bill and check their finance page — do the industries listed above match the groups funding their campaigns? That's the kind of connection this tool is built to help you find.
Subjects
Health
Read the full bill text